Latest Share Chat

IN BRIEF: PureTech Health's Akili secures USD160 million in financing

Wed, 26th May 2021 18:03

PureTech Health PLC - clinical-stage biotherapeutics company - Notes investee Akili Interactive has secured USD160 million of combined equity and debt financing. Says funding will accelerate commercialization of Akili's flagship treatment EndeavorRx, enable expansion of Akili's core technology to treat acute and chronic cognitive disorders, and drive further research and development of new technologies to treat broader range of conditions.

Current stock price: 378.50p

Year-to-date change: down 5.4%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Related Shares

More News

25 Apr 2024 10:07

Puretech Health operating losses narrow in 'landmark year'

(Sharecast News) - Biotechnology company Puretech Health said on Thursday that 2023 had been "a landmark year" for the group, making "strong strategic...

25 Apr 2024 09:59

PureTech touts "momentum" as grants shrivel but annual loss narrows

(Alliance News) - PureTech Health PLC on Thursday maintained an optimistic outlook for the year ahead, despite seeing annual revenue fall.

25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover